Cutibacterium acnes –Derived Extracellular Vesicles Promote Epithelial Ovarian Cancer Progression by Activating the KEAP1 – NRF2 Antioxidant Pathway to Suppress Ferroptosis

Read full text
Authors: Qifa Huang, Qi Chen, Qi Chen, Wenjie Xiong, Yuexi Sun, Yinghao Huang, Ang Dai, Jianying Chen, Xue Wu, Ying Jiang, Fen Wei, Qi Chen
+2 more Qi Chen, Tingtao Chen
Cited by: 1
References: 39

Abstract

Bacterial extracellular vesicles are increasingly recognized as important mediators of microbe-host communication, yet their functional roles within tumour-associated microbiota remain poorly understood. Here, we investigated whether extracellular vesicles derived from Cutibacterium acnes (CEVs) regulate host redox metabolism and ferroptosis in epithelial ovarian cancer (EOC). Using integrated in vitro and in vivo models, we found that CEVs significantly promoted tumour growth and induced transcriptional reprogramming toward antioxidant defence and ferroptosis resistance. Mechanistically, CEVs activated the KEAP1-NRF2 signalling axis through coordinated downregulation of ACSL4 and KEAP1, leading to enhanced glutathione biosynthesis, increased GPX4 activity, reduced lipid peroxidation and decreased intracellular reactive oxygen species levels. These metabolic alterations suppressed ferroptosis and promoted tumour cell survival. Importantly, pharmacological induction of ferroptosis using RSL3 abolished the tumour-promoting effects of CEVs, demonstrating that ferroptosis suppression is essential for CEVs-mediated tumour progression. Collectively, our findings identify bacterial extracellular vesicles as functional modulators of host redox metabolism and ferroptosis, revealing a previously unrecognized mechanism by which tumour-associated microbiota influence cancer progression.

Fields of Study & Subjects

Ferroptosis and cancer prognosis interferon and immune responses Extracellular vesicles in disease

Publication details

Journal / source
Microbial Biotechnology
Publisher
Wiley
Volume
19
Issue
5
Pages
e70373–e70373
Publication date
1 May 2026
Language
EN